alzheimer’s disease 2

46
HARSHITA II nd YEAR A.B.C.O.N ALZHEIMER’S DISEASE

Upload: harshunegi19

Post on 07-May-2015

929 views

Category:

Health & Medicine


2 download

TRANSCRIPT

Page 1: Alzheimer’s disease 2

HARSHITAII nd YEARA.B.C.O.N

ALZHEIMER’S DISEASE

Page 2: Alzheimer’s disease 2

• Alzheimer is a disease that attacks brain. It is most common form of DEMENTIA.

• Dementia is a general term for a decline in mental ability severe enough to interfere with daily life.

• In Alzheimer's disease there is a progressive loss of brain cells.

• Also known as AD.

ALZHEIMER

Page 3: Alzheimer’s disease 2

ALZHEIMER BRAIN

Page 4: Alzheimer’s disease 2

ETIOLOGY

• The exact aeitopathogenesis is not known

• The hypotheses include cholinergic hypothesis (reduced acetylcholine), amyloid hypothesis, and tau hypoth

Page 5: Alzheimer’s disease 2

PATHOLOGY

• It consist principally of neuronal loss ; principally in temporal cortex but also in the frontal cortex.

• Senile plaques and neurofibrially tangles are regarded as hallmark of AD though they may also be present with normal again

Page 6: Alzheimer’s disease 2

PATHO -PHYSIOLOGY

• Alzheimer's disease is characterized by loss of neurons and synapses in the cerebral cortex and certain sub cortical regions.

• This loss results in gross atrophy of the affected regions, including degeneration in the temporal lobe and parietal lobe, and parts of the frontal cortex and cingulated gyrus

Page 7: Alzheimer’s disease 2

LABORATORY INVESTIGATION

• These are carried out to exclude a treatable cause of dementia.

• Common investigation are blood chemistry, a complete count, test for syphilis, serum levels of vitamin B12 and thyroid function.

• A CT scan of head is usually done to exclude an intracranial pathology.

Page 8: Alzheimer’s disease 2

CONTINUE• A MRI may be necessary to detect

presence of white matter ischemic lesions.

Page 9: Alzheimer’s disease 2

CAUSES• Alzheimer's disease is caused by

parts of the brain wasting away (atrophy), which damages the structure of the brain and how it works.

• It is not known exactly what causes this process to begin, but people with Alzheimer's disease have been found to have abnormal amounts of protein (amyloid plaques) and fibers (tau tangles) in the brain

Page 10: Alzheimer’s disease 2
Page 11: Alzheimer’s disease 2

CONTINUE

• These reduce the effectiveness of healthy neurons (nerve cells that carry messages to and from the brain), gradually destroying them.

• Over time, this damage spreads to other areas of the brain, such as the grey matter (responsible for processing thoughts) and the hippocampus (responsible for memory).

Page 12: Alzheimer’s disease 2

SIGN AND SYMPTOMS• The symptoms of Alzheimer’s

disease progress slowly over several years. However, the rate at which they progress will differ for each individual.

• No two cases of Alzheimer's disease are ever the same because different people react in different ways to the condition. However, generally, there are three stages to the condition:-

Page 13: Alzheimer’s disease 2

CONTINUE

Mild Alzheimer's diseaseCommon symptoms of mild

Alzheimer's disease include:• forgetfulness • mood swings• speech problems

Page 14: Alzheimer’s disease 2

CONTINUE

Moderate Alzheimer's diseaseAs Alzheimer's disease develops into

the moderate stage, it can also cause:

• Disorientation• Difficulty performing spatial tasks

(such as judging distances or finding your way around)

Page 15: Alzheimer’s disease 2

CONTINUE

• Problems with eyesight which could lead to poor vision, or in some cases hallucinations (where you hear or see things that are not there)

• Delusions – believing things that are untrue

• Obsessive or repetitive behaviour

Page 16: Alzheimer’s disease 2

CONTINUE

• A belief that you have done or experienced something that never happened

• Disturbed sleep• Incontinence – where you

unintentionally pass urine (urinary incontinence) or stools (faecal or bowel incontinence

Page 17: Alzheimer’s disease 2

CONTINUE

Severe Alzheimer's disease• Dysphagia (difficulty swallowing)• Difficulty changing position or

moving from place to place without assistance

• Weight loss or a loss of appetite• Increased vulnerability to infection

Page 18: Alzheimer’s disease 2

CONTINUE

• Complete loss of short-term and long-term memory

• Someone with severe Alzheimer's disease may seem very disorientated and is likely to experience hallucinations and delusions.

Page 19: Alzheimer’s disease 2

CONTINUE

• The hallucinations and delusions are often worse at night, and the person with Alzheimer's disease may start to become violent, demanding, and suspicious of those around them.

Page 20: Alzheimer’s disease 2

TREATMENT

MedicationMedications that may be prescribed for

Alzheimer’s disease include:• Donepezil 5mg daily • Galantamine 4mg twice a day • Rivastigmine 1.5mg twice a day

Page 21: Alzheimer’s disease 2

CONTINUE

Side effectsDonepezil, galantamine and rivastigmine

(AChE inhibitors) can cause side effects including:

• nausea (feeling sick)• vomiting• diarrhoea• headache • fatigue (extreme tiredness)• insomnia

Page 22: Alzheimer’s disease 2

NURSING MANAGEMENT

Page 23: Alzheimer’s disease 2

Nurse’s Role

• Promote independence and autonomy

• Prevent complications• Provide comfort• Promote quality of life• Education

Page 24: Alzheimer’s disease 2

Planning Care

• No cure available• Goals of treatment

–Slow progression–Manage manifestations

• Care giver experience needed–Long-term care–End-of-life care

Page 25: Alzheimer’s disease 2

Planning Care

• Challenging behaviors and psychiatric symptoms develop in the AD patient

• Settings used to care for AD patients– Individual’s home or family member’s

home– Hospitals– Long-term-care facilities (nursing homes)– Congregate living facilities– Hospice settings

Page 26: Alzheimer’s disease 2

Pharmacological Interventions

• Cholinesterase inhibitors–Slow progression of symptoms–Titrate dosages slowly

• Donepezil (Aricept)• Rivastigmine (Exelon)• Galantamine (Reminyl

Page 27: Alzheimer’s disease 2

CONTINUE• Memantine (Namenda)

– N-methyl-d-aspartate (NMDA) antagonist• Alternative and complementary therapies

– Vitamin E: limited support, more study needed

– Nonsteroidal anti-inflammatory drugs/statins: patients taking these have reduced development of AD

– Statins:are a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG- CoA reductase.

Page 28: Alzheimer’s disease 2

Functional Impairments

• Utilize therapeutic nonverbal behaviors

• Avoid fatigue, nonroutine activities, and alcohol

• Avoid a high-stimulus environment• Prevent disability• Treat other conditions that lead to

physical decline

Page 29: Alzheimer’s disease 2

CONTINUE

• Identify and respond rapidly to acute changes in function

• Adapt care to accommodate neuro motor changes secondary to progression of dementia

Page 30: Alzheimer’s disease 2

Mood Disorders

• Be alert for changes–Appetite–Disinterest–Anhedonia–Sleep abnormality–Fatigue

Page 31: Alzheimer’s disease 2

Delusions and Hallucinations

• Cause–Delirium– Interaction of dementia and

personality–Separate mental disorder

coexisting with dementia–Disinhibition of cortical functions

Page 32: Alzheimer’s disease 2

Dependence in ADLs

• Promote, preserve functional independence

• Preventive plans of care

Page 33: Alzheimer’s disease 2

Inability to Initiate Meaningful Activities

• Results in apathy or agitation for dementia sufferer

• Promote social involvements

Page 34: Alzheimer’s disease 2

Anxiety• May be a primary disorder or a

symptom of depression• May result from delusions,

hallucinations, or functional impairment

• Plan interventions to reduce stress, enhance feelings of trust and safety

• Promote stability• Provide diversion activities

Page 35: Alzheimer’s disease 2

Spatial Disorientation

• Results in incorrect interpretation of objects or directions

• Results in fear, anxiety, suspicions, illusions, delusions, and safety concerns

• Promote familiarity with environment• Use landmarks to provide “pop-up”

cues

Page 36: Alzheimer’s disease 2

Elopement

• means to run away, and to not come back to the point of origination

• A valid concern in individuals with cognitive impairments

• Risk factors• Alzheimer’s Association Safe Return

Program

Page 37: Alzheimer’s disease 2

Resistance to Care• Common in middle to late stages of

dementia• Major reason for institutionalization

and use of psychotropic medications and restraints

• Management strategies–Restore calm–Time-out

Page 38: Alzheimer’s disease 2

Food Refusal

• Occurs in each of the progressive stages of AD

• Causes• Management interventions

Page 39: Alzheimer’s disease 2

Insomnia

• Insomnia noted months prior to AD diagnosis

• Establish routines to promote therapeutic sleep patterns–Establish sleep hygiene–Eliminate stimuli before bedtime

Page 40: Alzheimer’s disease 2

Apathy and Agitation

• Associated with increasing cognitive decline

• Escalation can result in violence and combative behaviors

• Promote interest in the environment

Page 41: Alzheimer’s disease 2

PharmacologicaL Interventions

• Used to promote comfort• Begin with lower dosages and

gradually increase• Monitor side effects closely

Page 42: Alzheimer’s disease 2

Late Stage Issues

• Institutionalization• Do not resuscitate decisions• Transfer to acute care facilities • Feeding tubes• Infections

Page 43: Alzheimer’s disease 2

PREVENTION• Quitting smoking• Avoid drinking large amounts of

alcohol• Eating a healthy balanced diet• Exercising for at least 150 m• If you have Diabetes, make sure you

keep to the diet and take and medicines

Page 44: Alzheimer’s disease 2
Page 45: Alzheimer’s disease 2
Page 46: Alzheimer’s disease 2

THANK YOU